Efficacy and Nursing of Torasemide in the Treatment of Cerebral Hemorrhage
Cerebral edema is a common pathological change in patients with acute cerebral hemorrhage. At present, there are many controversies in the clinical use of dehydration and intracranial pressure drugs, such as sputum and mannitol, due to side effects such as electrolyte imbalance and kidney damage. This article was to observe the efficacy of torasemide and dexamethasone in the treatment of brain edema after acute cerebral hemorrhage and its effect on electrolytes. The observation group was given torsemide treatment, the control group was given dexamethasone combined with mannitol, and the head CT was performed to calculate the intracranial hematoma and cerebral edema volume. After statistical analysis, the cerebral edema volume, intracranial pressure and comprehensive interference coefficient of the observation group were lower than that of the control group after 48 h, 7 d, and 14 d after treatment. The cerebral edema grade of the observation group was statistically significant compared with the control group at 14 d after treatment. . After treatment, the effective rate of treatment of cerebral edema in the observation group was significantly higher (87%) than in the control group (65%), and the incidence of adverse reactions was significantly lower than that of the control group. In the control group, 45% of patients had abnormalities of blood electrolyte sodium, mostly low sodium and/or low potassium; 28% of the observation group had blood electrolyte abnormalities. Torasemide is effective in treating cerebral edema after acute cerebral hemorrhage, and the incidence of adverse reactions is low, and the neurological function and life ability score of patients are significantly improved, which is worthy of clinical application.